Eurofarma Laboratorios S.A.
Eurofarma Laboratorios S.A.
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Phase 3 | 2026-09-22 | NCT06905210 | |
| Efficacy and Safety of Two Fixed-dose Combinations in Men With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia. (BENIPRO) | Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms | Not yet recruiting | Phase 3 | 2026-09-22 | NCT06546735 | |
| Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR) | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Not yet recruiting | Phase 3 | 2026-09-22 | NCT06234345 | |
| Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA) | Contraception | Not yet recruiting | Phase 3 | 2026-07-21 | NCT07714616 | |
| Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, androgenetic alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Not yet recruiting | Phase 3 | 2026-04-14 | NCT07529977 | |
| Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN) | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Not yet recruiting | Phase 3 | 2026-01-09 | NCT07303322 | |
| Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN) | Dyssomnias, Sleep Disorders, Intrinsic, cardiovascular disorder, hypertensive disorder, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder, vascular disorder | Recruiting | Phase 4 | 2025-06-12 | NCT07018557 | |
| Evaluation of the EF192B Protection Versus No Treatment | Skin Care; Skin Lesions | Not yet recruiting | Not applicable | 2024-12-30 | NCT06752460 |